Key stats
About PROGEN
Sector
Headquarters
Seoul
Website
Founded
1998
ISIN
KR7296160005
FIGI
BBG01K2R7PZ1
ProGen Co., Ltd. is a biotechnology company, which engages in the research and development of antibody therapeutics. It offers Neo Tri-ImmunoGlobulin (NTIG), a platform technology optimized for the development of anti-cancer and immune disease treatments with multi-targeting. The company was founded on October 21, 1998 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 296160 is 6010 KRW — it has increased by 0.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange PROGEN stocks are traded under the ticker 296160.
296160 stock is 1.01% volatile and has beta coefficient of −0.26. Check out the list of the most volatile stocks — is PROGEN there?
296160 stock has fallen by 0.33% compared to the previous week, the month change is a 13.65% fall, over the last year PROGEN has showed a 27.47% increase.
No, 296160 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 296160 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROGEN stock right from TradingView charts — choose your broker and connect to your account.